MIB-1 Labeling Index as a Prognostic Indicator for Survival in Patients with FIGO Stage IB Squamous Cell Carcinoma of the Cervix
- 31 January 2000
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 76 (1) , 97-102
- https://doi.org/10.1006/gyno.1999.5663
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumorsHuman Pathology, 1998
- MIB-1 labelling index is an independent prognostic marker in primary breast cancerBritish Journal of Cancer, 1998
- The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinomaEuropean Journal Of Cancer, 1997
- MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomasCell Proliferation, 1997
- Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67British Journal of Cancer, 1988
- A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1987
- Prognostic factors and operative treatment of Stages IB to IIB cervical cancerAmerican Journal of Obstetrics and Gynecology, 1987
- The combination of radiotherapy and surgery in the treatment of carcinoma of the uterine cervixThe British Journal of Radiology, 1986
- INVASIVE CARCINOMA OF THE CERVIX IN YOUNGER WOMENThe Lancet, 1983
- Prognostic factors in stage I carcinoma of the cervixGynecologic Oncology, 1981